(Q42502939)

1 November 2017

Metabolic and immunological effects of cyclosporin in recently diagnosed type 1 diabetes mellitus (English)

1 reference

1 November 2017

0 references

R Assan

1

1 reference

1 November 2017

G Feutren

2

1 reference

1 November 2017

M Debray-Sachs

3

1 reference

1 November 2017

M C Quiniou-Debrie

4

1 reference

1 November 2017

C Laborie

5

1 reference

1 November 2017

G Thomas

6

1 reference

1 November 2017

L Chatenoud

7

1 reference

1 November 2017

J F Bach

8

1 reference

1 November 2017

language of work or name

English

0 references

publication date

1 January 1985

1 reference

1 November 2017

1 reference

1 November 2017

1

1 reference

1 November 2017

67-71

1 reference

1 November 2017

8420

1 reference

Islet-cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiencies

1 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2885%2991964-6

7 January 2021

Insulin-dependent diabetes mellitus: the initial lesion

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2885%2991964-6

7 January 2021

Spontaneous Diabetes Mellitus: Reversal and Prevention in the BB/W Rat with Antiserum to Rat Lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2885%2991964-6

7 January 2021

Cyclosporin prevents diabetes in BB Wistar rats

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2885%2991964-6

7 January 2021

Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. National Diabetes Data Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2885%2991964-6

7 January 2021

Cytotoxic autoantibodies to beta cells in the serum of patients with insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2885%2991964-6

7 January 2021

Complement-fixing Islet cell antibodies from some diabetic patients alter insulin release in vitro.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2885%2991964-6

7 January 2021

Abnormalities of T-cell subsets in glomerulonephritis and systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2885%2991964-6

7 January 2021

A Radioimmunoassay to Measure Cyclosporin a in Plasma and Serum Samples

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2885%2991964-6

7 January 2021

Effects of Cyclosporine Immunosuppression in Insulin-Dependent Diabetes Mellitus of Recent Onset

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2885%2991964-6

7 January 2021

Cyclosporine-associated chronic nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2885%2991964-6

7 January 2021

Lymphomas and lymphoproliferative lesions developing under cyclosporin therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2885%2991964-6

7 January 2021

10.1016/S0140-6736(85)91964-6

Identifiers

DOI

1 reference

1 November 2017

1 reference